A Oneindia Venture
Get Updates
Get notified about market trends, financial advice, and investment tips!
Click it and Unblock the Notifications
Tata India Pharma & HealthCare Fund
Regular
Direct
3 Year Absolute Returns
75.82% ↑
NAV (₹) on 12 Jun 2026
30.21
1 Day NAV Change
0.61%
Risk Level
Very High Risk
Rating
-
Tata India Pharma & HealthCare Fund is a Equity mutual fund categorized under Sector, offered by Tata Asset Management Ltd.. Launched on 04 Dec 2015, investors can start with a minimum SIP of ₹100 or ... Read more
NAV History
Fund Details
Min. SIP Amount
₹150
Inception Date
04 Dec 2015
Min. Lumpsum Amount
₹ 5,000
Fund Age
10 Yrs
AUM
₹ 1,386.99 Cr.
Benchmark
BSE Healthcare Total Return
Expense Ratio
2.08%
Scheme Type
Open Ended
Exit Load
0.25%
Returns Calculator
Investment amount per month
₹1,000
Over the past
Would have become
On total investment of
*Calculation based on past performance of this fund.
Asset Allocation
AUM
₹ 1,386.99 Cr
Equity
486.98%
Money Market & Cash
13.02%
Sector Holdings
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 63.20% |
| Hospitals & Medical Services | 30.40% |
| Agro Chemicals/Pesticides | 3.95% |
| Personal Care | 1.35% |
| Cash | 0.47% |
| Finance - Life Insurance | 0.40% |
| CBLO/Reverse Repo | 0.23% |
Stock Holdings
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD | 9.38% | ₹ 130.11 | Pharmaceuticals |
| HEALTHCARE GLOBAL ENTERPRISES LTD | 5.87% | ₹ 81.36 | Hospitals & Medical Services |
| DIVI LABORATORIES LTD | 5.80% | ₹ 80.40 | Pharmaceuticals |
| ABBOTT INDIA LTD | 5.41% | ₹ 75.07 | Pharmaceuticals |
| CIPLA LTD | 5.18% | ₹ 71.84 | Pharmaceuticals |
| MAX HEALTHCARE INSTITUTE LTD | 4.80% | ₹ 66.64 | Hospitals & Medical Services |
| APOLLO HOSPITALS ENTERPRISE LTD | 4.56% | ₹ 63.24 | Hospitals & Medical Services |
| RAINBOW CHILDRENS MEDICARE LTD | 4.52% | ₹ 62.71 | Hospitals & Medical Services |
| DR REDDYS LABORATORIES LTD | 4.02% | ₹ 55.80 | Pharmaceuticals |
| MANKIND PHARMA LTD | 3.77% | ₹ 52.27 | Pharmaceuticals |
| FORTIS HEALTHCARE LTD | 3.41% | ₹ 47.29 | Hospitals & Medical Services |
| GLAXOSMITHKLINE PHARMACEUTICALS LTD | 3.26% | ₹ 45.25 | Pharmaceuticals |
| BAYER CROPSCIENCE LTD | 3.10% | ₹ 43.06 | Agro Chemicals/Pesticides |
| LUPIN LTD | 2.76% | ₹ 38.27 | Pharmaceuticals |
| SAI LIFE SCIENCES LTD | 2.73% | ₹ 37.81 | Pharmaceuticals |
| SYNGENE INTERNATIONAL LTD | 2.65% | ₹ 36.82 | Pharmaceuticals |
| ALKEM LABORATORIES LTD | 2.42% | ₹ 33.61 | Pharmaceuticals |
| J.B.CHEMICALS & PHARMACEUTICALS LTD | 2.24% | ₹ 31.03 | Pharmaceuticals |
| GLOBAL HEALTH LTD | 2.20% | ₹ 30.50 | Hospitals & Medical Services |
| FDC LTD | 2.12% | ₹ 29.38 | Pharmaceuticals |
| NEULAND LABORATORIES LTD | 1.89% | ₹ 26.17 | Pharmaceuticals |
| AJANTA PHARMA LTD | 1.89% | ₹ 26.19 | Pharmaceuticals |
| PROCTER & GAMBLE HEALTH LTD | 1.80% | ₹ 24.91 | Pharmaceuticals |
| DR. LAL PATH LABS LTD | 1.68% | ₹ 23.32 | Hospitals & Medical Services |
| METROPOLIS HEALTHCARE LTD | 1.64% | ₹ 22.75 | Hospitals & Medical Services |
| PFIZER LTD | 1.63% | ₹ 22.58 | Pharmaceuticals |
| SANOFI INDIA LTD | 1.46% | ₹ 20.21 | Pharmaceuticals |
| GILLETTE INDIA LTD | 1.35% | ₹ 18.67 | Personal Care |
| VIJAYA DIAGNOSTIC CENTRE LTD | 1.14% | ₹ 15.83 | Hospitals & Medical Services |
| TORRENT PHARMACEUTICALS LTD | 1.02% | ₹ 14.15 | Pharmaceuticals |
| CONCORD BIOTECH LTD | 0.77% | ₹ 10.71 | Pharmaceuticals |
| DR. AGARWALS HEALTH CARE LTD | 0.58% | ₹ 8.08 | Hospitals & Medical Services |
| JUBILANT PHARMOVA LTD | 0.55% | ₹ 7.59 | Pharmaceuticals |
| SUMITOMO CHEMICAL INDIA LTD | 0.49% | ₹ 6.85 | Agro Chemicals/Pesticides |
| CASH / NET CURRENT ASSET | 0.47% | ₹ 6.42 | Others |
| CORONA REMEDIES LTD | 0.45% | ₹ 6.29 | Pharmaceuticals |
| HDFC LIFE INSURANCE CO. LTD | 0.40% | ₹ 5.56 | Finance - Life Insurance |
| PI INDUSTRIES LTD | 0.36% | ₹ 4.98 | Agro Chemicals/Pesticides |
| REPO | 0.23% | ₹ 3.22 | Others |
Returns
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | -2.56% | 0.78% | 7.42% | 20.69% |
| Category returns | 0.62% | 3.05% | 6.80% | 22.01% |
Fund Objective
The investment objective of the scheme is to seek long term capital appreciation by investing at least 80% of its net assets in equity/equity related instruments of the companies in the pharma & ... Read more
AMC Details
Name
Tata Asset Management Ltd.
Date of Incorporation
30 Jun 1995
CEO
Mr. Prathit Bhobe
CIO
Mr. Rahul Singh
Type
Pvt.Sector-Indian
Address
1903, B-Wing, Parinee Crescenzo,
G-Block, Bandra Kurla Complex,
Bandra East, Mumbai, Maharashtra, India - 400051
Website
http://www.tatamutualfund.com
Email
Top Funds from Equity - Sectoral/Thematic
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹38.25 | 192.52% | 336.97% | 0.00% | ₹1,256 | 0.85% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹38.25 | 192.52% | 336.97% | 0.00% | ₹1,256 | 0.85% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹38.25 | 192.52% | 336.97% | 0.00% | ₹1,256 | 0.85% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹35.83 | 188.54% | 319.22% | 0.00% | ₹1,256 | 2.15% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹35.83 | 188.54% | 319.22% | 0.00% | ₹1,256 | 2.15% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹35.83 | 188.54% | 319.22% | 0.00% | ₹1,256 | 2.15% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹28.67 | 12.07% | 185.26% | 0.00% | ₹9,724 | 0.83% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹28.67 | 12.07% | 185.26% | 0.00% | ₹9,724 | 0.83% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹28.67 | 12.07% | 185.26% | 0.00% | ₹9,724 | 0.83% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹27.71 | 10.94% | 175.86% | 0.00% | ₹9,724 | 1.75% |
Very High
|
Top Funds from Tata Asset Management Ltd.
FAQs
What is the current NAV of Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment?
The current Net Asset Value (NAV) of Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment is ₹30.21 as of 12 Jun 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment?
The Assets Under Management (AUM) of Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment is ₹1,386.99 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment?
Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment has delivered returns of 0.78% (1 Year), 20.69% (3 Year), 12.05% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment?
Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment?
The minimum lumpsum investment required for Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment is ₹5,000. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹150, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
-
ನಿಫ್ಟಿ ಸ್ಮಾಲ್ಕ್ಯಾಪ್ 250 ಎನ್ಎಫ್ಒ: ಹೂಡಿಕೆಗೂ ಮುನ್ನ ಈ ರಿಸ್ಕ್ ಬಗ್ಗೆ ನಿಮಗೆ ಗೊತ್ತಾ? -
ಮ್ಯೂಚುವಲ್ ಫಂಡ್ ಹೂಡಿಕೆದಾರರೇ ಎಚ್ಚರ! ಎಎಂಎಫ್ಐ ವರದಿಯಲ್ಲಿನ ಆಘಾತಕಾರಿ ಅಂಕಿಅಂಶಗಳು ಏನು ಹೇಳುತ್ತವೆ? -
ಗೋಲ್ಡ್ ಇಟಿಎಫ್ ಹೂಡಿಕೆದಾರರಿಗೆ ಶಾಕ್: ನಿಮ್ಮ ಹಣದ ಮೇಲೆ ನಿರ್ಬಂಧ ಹೇರಿದ್ದಾರೆಯೇ? -
ಎಸ್ಐಪಿ ಹೂಡಿಕೆಯಲ್ಲಿ ಹೊಸ ದಾಖಲೆ: ಮೇ ತಿಂಗಳ ಅಂಕಿಅಂಶಗಳು ನಿಮ್ಮ ಆರ್ಥಿಕ ಭವಿಷ್ಯಕ್ಕೆ ನೀಡುವ ಸಂದೇಶವೇನು? -
ಮ್ಯೂಚುವಲ್ ಫಂಡ್ ಮಾರಾಟ ಮಾಡದೆ ಹಣ ಪಡೆಯಿರಿ: ಯುಪಿಐ ಕ್ರೆಡಿಟ್ ಲೈನ್ನ ಅಚ್ಚರಿಯ ಲಾಭಗಳಿವು! -
ಸಂಬಳ ಬರುವ ಮುನ್ನವೇ ಹೂಡಿಕೆ! ಸೆಬಿಯ ಹೊಸ 'ಪೇರೋಲ್ ಎಸ್ಐಪಿ' ನಿಮ್ಮ ಉಳಿತಾಯದ ಶೈಲಿಯನ್ನೇ ಬದಲಿಸಲಿದೆಯೇ? -
ಇನ್ಮುಂದೆ ಸಂಬಳ ಬರುವ ಮುನ್ನವೇ ಮ್ಯೂಚುವಲ್ ಫಂಡ್ ಹೂಡಿಕೆ: ಸೆಬಿಯ ಹೊಸ ಪ್ಲಾನ್ ನಿಮಗೇನು ಲಾಭ? -
ಮ್ಯೂಚುವಲ್ ಫಂಡ್ನಲ್ಲಿ ಐಟಿ ಷೇರುಗಳ ಭಾರಿ ಕಡಿತ: ನಿಮ್ಮ ಎಸ್ಐಪಿ ಹೂಡಿಕೆ ಈಗ ಅಪಾಯದಲ್ಲಿದೆಯೇ? -
ಮ್ಯೂಚುವಲ್ ಫಂಡ್ ಹೂಡಿಕೆದಾರರಿಗೆ ಸೆಬಿಯಿಂದ ಸಿಹಿಸುದ್ದಿ: ಇನ್ಮುಂದೆ ನಿಮ್ಮ ಹಣ ಹಿಂಪಡೆಯುವುದು ಇನ್ನಷ್ಟು ಸುಲಭ! -
ಮಾರುಕಟ್ಟೆ ಏರಿಳಿತದ ನಡುವೆಯೂ ದಾಖಲೆ ಬರೆದ ಹೂಡಿಕೆದಾರರು: ಎಸ್ಐಪಿ ಹೂಡಿಕೆಯಲ್ಲಿ ಭರ್ಜರಿ ಏರಿಕೆ!
Top Mutual Fund House in India
Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Stay Informed.
Get news and videos anytime and anywhere.
Sign in with Google By signing in, you agree to our Terms and Privacy Policy
Gender
Select your Gender
- Male
- Female
- Others
Age
Select your Age Range
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+